Ondansetron
- Product NDC
- 45865-563
- 11-digit product format
- 458650563
- Labeler code
- 45865
- Product ID
- 45865-563_9ab32a0e-d268-0c50-e053-2a95a90abb20
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ondansetron
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Medsource Pharmaceuticals
- Application
- ANDA090469
- Marketing category
- ANDA
- Marketing start
- 2010-04-12
- Marketing end
- 0000-00-00
- Substance
- ONDANSETRON
- Active strength
- 8 mg/1
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 45865-563-10 | Ondansetron | 10 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 10 | | 2 |
| 45865-563-30 | Ondansetron | 30 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 45865-563 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [MEDSOURCE PHARMACEUTICALS] | 2 | Legacy NDC, 2 package rows | 20191228_1eb89f6e-6e01-5812-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45865-563-10 | 45865056310 | 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (45865-563-10) | 2015-09-01 | 0000-00-00 | No | No | Current |
| 45865-563-30 | 45865056330 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (45865-563-30) | 2015-09-01 | 0000-00-00 | No | No | Current |